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Monday, March 7, 2011 315acan be combined with other techniques, such as fluorescence and polarization
microscopy.
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Ellagic Acid Nanotubular and Poly-Cationic Conjugates as Nano-Carriers
for Delivery into Mammalian Cells
Stacey N. Barnaby, Karl R. Fath, Areti Tsiola, Ipsita A. Banerjee.
Ellagic acid (EA) is a naturally occurring plant polyphenol formed by the hy-
drolysis of ellagitannins, which are primarily found in grapes, nuts and fruits.
EA has been known to have potent anticarcinogenic activities, however, its in-
solubility under physiological conditions limits its potential applications. In
this work, we have prepared complexes of ellagic acid with peptide nanotubes
and polycations such as low molecular weight polyethylenimine (PEI), polyar-
ginine and polylysine to enhance its properties for drug delivery. In particular,
polycations such as PEI are well known non-viral vectors. Briefly, EA nanofib-
ers were grown by self-assembly and were complexed with peptide nanotubes
or poly cations at varying temperature and pH. The formation of the nanocom-
plexes was confirmed by zeta-potential analysis. The morphologies of the com-
plexes were examined by electron microscopy. Because of the rigid core of EA
that offers shape consistence, and the poly-cation shells that passivate the sur-
faces, coreshell nanoconjugates whose average diameters were dependent
upon the concentrations and pH were formed. In the formed complexes, the
charged amine groups of the polycations most likely interact with the partially
deprotonated carboxylate and hydroxyl groups of EA. In some cases, the EA
was coupled with rhodamine to examine the effect of bound versus unbound
nanocomplexes formed using confocal microscopy. The interactions of the
complexes with mammalian cells were examined by live-cell imaging in the
presence of normal rat kidney cells. The anticarcinogenic effects of the nanop-
robes was explored using HeLa cells. Finally, the ability of the nanocomplexes
for drug release was examined at varying pH and concentrations. Such
nanocomplexes may have potential applications not only for anticarcinogenic
activities but may also help probe mechanisms involved with EA based biode-
gradable polycationic-based delivery and cellular attachment towards use in
varying therapeutic applications.
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Single-Cell Oxygen Consumption Measurements in Bacteria Using a
Microobservation Chamber
Michael C. Konopka, David S. Ojala, Samuel Levine, Sarah C. McQuaide,
Ekaterina Latypova, Marina G. Kalyuzhnaya, Mary E. Lidstrom.
Respiration can be a powerful parameter for assessing the physiological state of
cells or aiding in determining metabolic functions of cells in a natural sample.
Both of these approaches benefit from single cell methodology to ensure that
the analysis targets individual cells as opposed to the population average. Using
a Respiration Detection System: Microobservation Chamber (RDS:MC), we
are able to isolate single cells and measure their consumption of oxygen
in real time. The cells are seeded on a chip comprised of an array of microwells
containing Pt-porphyrin embedded microspheres. A lid actuator allows for
sealing of the microwells for single cell oxygen consumption measurements,
as well as opening the microwells for reoxygenation. The phosphorescence
lifetime of the Pt-porphyrin varies based on the oxygen concentration, so
the decreasing oxygen level in the well after sealing can be monitored
by optimized rapid lifetime determination (ORLD). This platform can be
coupled with other microscopy techniques, such as fluorescence microscopy
or NanoSIMS.
Single cell oxygen consumption measurements give an indication a cell’s phys-
iological state and provide an additional tool for assessing cell-to-cell variation.
For environmental samples, the RDS:MC allows for the detection of microbes
carrying a specific biochemical transformations by monitoring respiration
before and after the addition of a substrate. Thus RDS:MC holds the potential
to determine the functional role of yet uncultivable microbes by monitoring
respiration before and after the addition of a substrate. Cells that show a
response to the substrate can be selected for further genomic analysis.
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Simultaneous Real-Time Measurements of 10,000 Antibody-Antigen
Reactions Using a Label-Free Scanning Ellipsometric Microscope
James P. Landry, Xiangdong Zhu.
Phage display and similar techniques produce large combinatorial libraries of
antibodies. The libraries must be screened by high-throughput technologies
to select antibodies with desired binding specificities and physicochemical
properties (e.g. on-rates, off-rates, binding affinities) for applications from
basic research to human disease therapy. Microarrays can contain tens of thou-
sands of antigens or antibodies on a 1’’x3’’ chemically functionalized glass
slide, matching the required throughput. However, traditional fluorescence-
based microarray detection doesn’t directly give kinetic information, only reac-tion endpoints. Furthermore, modification of an antibody (or other proteins)
with a fluorophore can alter binding kinetics and affinity [Sun et al., Langmuir
24 (2008), 13399]. We have developed ellipsometry-based scanning optical
microscopes for high-throughput and label-free readout of microarrays. Our
microscopes sense the mass density of proteins or other biomolecules on a sub-
strate through the disproportionate change of s- and p-polarized Fresnel coeffi-
cients of obliquely reflected light. Our scanning microscopes can operate in
a ‘‘high spatial-resolution’’ scanning mode, yielding end-point images of
a 2x4 cm2 microarray installed in a flow cell. This area can bear at least
10,000 printed biomolecular spots. Moreover, the microscopes can operate in
a ‘‘high-speed’’ (coarse resolution) scanning mode, allowing the binding kinet-
ics of all 10,000 microarray spots to be measured simultaneously. We demon-
strate this capability by measuring the on-rates, off-rates, and equilibrium
dissociation constants of antibodies exposed to a ~10,000 spot antigen micro-
array. For high-affinity binders with small off-rates, the long dissociation time
needed can reduce the overall throughput and may not be known beforehand. In
such cases, we present a method for estimating an upper bound for the off-rate
when dissociation is measured for a limited time. This maintains the overall
throughput of early-stage assays while more detailed measurements, if needed,
can be performed latter.
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Seeing Theranostic Nano-Carriers by Freeze-Fracture Electron Micros-
copy
Brigitte Papahadjopoulos-Sternberg.
The potency of nano- and micro-particles, loaded with therapeutic and/or diag-
nostics is frequently depending upon their morphology adopted in biological
relevant environments. Freeze-fracture transmission electron microscopy
(ff-TEM) as a cryo-fixation, replica TEM method is a powerful technique to
monitor self-assembling of lipid-, polymer-, as well as protein/peptide-based
carriers encapsulating drug-, gene-, vaccine, antimicrobial- and imaging mole-
cules[1]. At a 2 nm resolution limit we are able to study structural modifications
of such carriers related to their pay load, application milieu, and during cell
interaction.
Using ff-TEM we studied the morphology of a wide variety of nano- and micro
particles suitable as carriers for diagnostics as well as therapeutics including
quantum dots (coupled to drug-loaded immunoliposomes)[2], gold nano-parti-
cles, superparamagnetic iron oxide nano-particles loaded in polymeric
immunomicelles[3], micelles (spherical-, disc-, and worm-type micelles)
[4,5], small unilamellar liposome[6], multilamellar liposome, niosomes, cat-
ionic liposome/DNA complexes, integrin-targeted lipopolyplexes[7], poly-
mer-, lipid- or surfactant-stabilized gas bubbles[8], cochleate cylinder,
depofoam particles, and drug crystals. Recently we explored liposome-, viro-
some-, and virus-based vaccines, including measles vaccine powders, by ff-
TEM. Furthermore, we explored structural modifications within bilayers such
as domain-formation [1] but also transformations to non-bilayer structures
such as hexagonal and cubic phases.
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Sizing Nanomatter in Biological Fluids by Fluorescence Single Particle
Tracking
Kevin Braeckmans, Kevin Buyens, Wim Bouquet, Chris Vervaet,
Philippe Joye, Filip De Vos, Loic Doeuvre, Laurent Plawinski,
Eduardo Angles-Cano, Niek N. Sanders, Jo Demeester, Stefaan C. De Smedt.
One of the major applications of nanotechnology in the life sciences is the de-
velopment of functional nanoparticles. Accurate nanoparticle characterisation
in biological media is a prerequisite to make the transition from the laboratory
to a successful product. For many applications, such as nanomedicines for tar-
geted drug delivery, it is essential to monitor the size of nanoparticles in the
blood circulation as this directly influences their biodistribution and processing
by target cells. However, due to a lack of suitable sizing methods, systematic
studies are missing and hamper development of improved nanoparticulate sys-
tems. Here we show that fluorescence single particle tracking (fSPT) with max-
imum entropy analysis is the first technique suited for accurate sizing of
nanoparticles dispersed in undiluted biofluids. The fSPT sizing method was
